Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain
- PMID: 23303498
- PMCID: PMC3666811
- DOI: 10.1128/JCM.02157-12
Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain
Abstract
Multiyear molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa (MRPA) in a pediatric cystic fibrosis care center identified an endemic MRPA strain (Houston-1). Recent hospitalization was found to be a statistically significant risk factor for acquisition of the endemic strain. Multiple infection control improvements led to the reduced incidence of the Houston-1 strain in the CF population.
Figures


Similar articles
-
Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.J Clin Microbiol. 2014 Apr;52(4):1127-35. doi: 10.1128/JCM.03218-13. Epub 2014 Jan 22. J Clin Microbiol. 2014. PMID: 24452167 Free PMC article.
-
A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.BMC Infect Dis. 2011 Oct 13;11:272. doi: 10.1186/1471-2334-11-272. BMC Infect Dis. 2011. PMID: 21995287 Free PMC article.
-
Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon.BMC Microbiol. 2025 Apr 9;25(1):203. doi: 10.1186/s12866-025-03920-w. BMC Microbiol. 2025. PMID: 40205346 Free PMC article.
-
[Various typing methods of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients].Med Mal Infect. 2008 May;38(5):238-47. doi: 10.1016/j.medmal.2008.02.005. Epub 2008 Apr 3. Med Mal Infect. 2008. PMID: 18394837 Review. French.
-
The increasing threat of Pseudomonas aeruginosa high-risk clones.Drug Resist Updat. 2015 Jul-Aug;21-22:41-59. doi: 10.1016/j.drup.2015.08.002. Epub 2015 Aug 10. Drug Resist Updat. 2015. PMID: 26304792 Review.
Cited by
-
Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.J Clin Microbiol. 2014 Apr;52(4):1127-35. doi: 10.1128/JCM.03218-13. Epub 2014 Jan 22. J Clin Microbiol. 2014. PMID: 24452167 Free PMC article.
-
Multidrug resistant Pseudomonas aeruginosa survey in a stream receiving effluents from ineffective wastewater hospital plants.BMC Microbiol. 2016 Aug 24;16(1):193. doi: 10.1186/s12866-016-0798-0. BMC Microbiol. 2016. PMID: 27558582 Free PMC article.
-
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.Antimicrob Agents Chemother. 2016 Oct 21;60(11):6735-6741. doi: 10.1128/AAC.01046-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27572406 Free PMC article.
-
Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities.Front Cell Infect Microbiol. 2020 Apr 24;10:173. doi: 10.3389/fcimb.2020.00173. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32426295 Free PMC article.
-
Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis.PLoS One. 2015 Dec 3;10(12):e0144022. doi: 10.1371/journal.pone.0144022. eCollection 2015. PLoS One. 2015. PMID: 26633539 Free PMC article.
References
-
- Cystic Fibrosis Foundation 2008. Patient registry: annual data report 2006. Cystic Fibrosis Foundation, Bethesda, MD.
-
- Falagas ME, Koletsi PK, Bliziotis IA. 2006. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol. 55:1619–1629 - PubMed
-
- Cystic Fibrosis Foundation 2011. Patient registry: annual data report 2010. Cystic Fibrosis Foundation, Bethesda, MD
-
- de Vrankrijker AM, Brimicombe RW, Wolfs TF, Heijerman HG, van Mansfeld R, van Berkhout FT, Willems RJ, Bonten MJ, van der Ent CK. 2011. Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients. Clin. Microbiol. Infect. 17:382–385 - PubMed
-
- Edenborough FP, Stone HR, Kelly SJ, Zadik P, Doherty CJ, Govan JR. 2004. Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation. J. Cyst. Fibros. 3:37–44 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases